Aaron Cardon
Neurology with Special Qualifications in Child Neurology · Albuquerque, NMNPI 1710284864
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,571 of the $3,442 with a category attached, or 74.7%. 28 manufacturers reported payments, led by Eisai Inc. at 31.5% of the total. Reporting peaked in 2019 at $2,202 and has fallen 89.2% since, to $238 in 2025.
Across 91 payments — averaging $37.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Eisai Inc.$1K
- Greenwich Biosciences, Inc.$559
- SK Life Science, Inc.$330
- Sunovion Pharmaceuticals Inc.$306
- Livanova USA, Inc.$218
- Neuropace, Inc.$144
- plus $800 from 22 others
Across 6 payments — averaging $2325.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Neuropace, Inc.$14K
What the payments were for
- Travel & lodging$81124%
- Food & beverage$2,57175%
- Education$612%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Eisai Inc. | 10 | $1,084 |
| Greenwich Biosciences, Inc. | 12 | $559 |
| SK Life Science, Inc. | 6 | $330 |
| Sunovion Pharmaceuticals Inc. | 14 | $306 |
| Livanova USA, Inc. | 6 | $218 |
| Neuropace, Inc. | 2 | $144 |
| Sanofi | 1 | $122 |
| DIXI Medical USA Corp | 1 | $101 |
| Aquestive Therapeutics, Inc. | 5 | $71 |
| Ironshore Pharmaceuticals Inc. | 5 | $68 |
| Neos Therapeutics, LP | 4 | $64 |
| Biogen | 3 | $45 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $33 |
| Tris Pharma Inc | 2 | $30 |
| Acadia Pharmaceuticals Inc | 2 | $29 |
| Amgen | 2 | $29 |
| Vertical Pharmaceuticals, LLC | 2 | $25 |
| PTC Therapeutics, Inc. | 1 | $23 |
| Antares Pharma, Inc. | 1 | $23 |
| Zogenix Inc. | 1 | $22 |
| Novartis Gene Therapies, Inc. (fka Avexis, Inc.) | 1 | $21 |
| Travere Therapeutics, Inc. | 2 | $20 |
| Mallinckrodt Hospital Products Inc. | 1 | $15 |
| Novartis | 1 | $14 |
| Ipsen Biopharmaceuticals, Inc | 1 | $12 |
| UCB, Inc. | 1 | $12 |
| Shire North American Group Inc | 1 | $12 |
| Adlon Therapeutics L.p. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Fycompa$921
- Epidiolex$403
- VNS THERAPY SENTIVA MODEL 1000 GENERATOR$136
- APTIOM$125
- XCOPRI$120
How this compares
Too few neurology with special qualifications in child neurology providers in New Mexicoto place this figure against a meaningful peer group, so we don't.
Other neurology with special qualifications in child neurology in Albuquerque
- Meeta CardonAlbuquerque$19K
- Leslie MorrisonAlbuquerque$13K
- Abby KunzAlbuquerque$861
- Harsheen KaurAlbuquerque$833
- Jennifer VickersAlbuquerque$178
- Nicola RossAlbuquerque$123
- John MasonAlbuquerque$100
- Kathy WolfeAlbuquerque$100
- Mary JohnsonAlbuquerque$80
- Russell SnyderAlbuquerque$24
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.